Balt introduced the Flow Diverter Stent two years ago, a first-in-class flow diverter device for the treatment of distal aneurysms with the benefits of excellent visibility and device deployment.
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
